Free Trial

GBS (GBS) Competitors

GBS logo
$2.14 +0.01 (+0.47%)
As of 07/17/2025

GBS vs. NSPR, CTCX, TMDIF, HSAQ, RVP, PETV, BTCY, INVO, TTOO, and DYNT

Should you be buying GBS stock or one of its competitors? The main competitors of GBS include InspireMD (NSPR), Carmell (CTCX), Titan Medical (TMDIF), Health Sciences Acquisitions Co. 2 (HSAQ), Retractable Technologies (RVP), PetVivo (PETV), Biotricity (BTCY), INVO Bioscience (INVO), T2 Biosystems (TTOO), and Dynatronics (DYNT). These companies are all part of the "surgical & medical instruments" industry.

GBS vs. Its Competitors

GBS (NYSE:GBS) and InspireMD (NYSE:NSPR) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, institutional ownership, profitability, analyst recommendations, risk, dividends, earnings and valuation.

GBS has higher earnings, but lower revenue than InspireMD. GBS is trading at a lower price-to-earnings ratio than InspireMD, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
GBSN/AN/A-$8.31M-$0.56-3.82
InspireMD$7.03M10.42-$19.92M-$0.79-3.03

GBS has a beta of 1.32, meaning that its share price is 32% more volatile than the S&P 500. Comparatively, InspireMD has a beta of 0.57, meaning that its share price is 43% less volatile than the S&P 500.

InspireMD has a consensus price target of $4.50, suggesting a potential upside of 88.28%. Given InspireMD's stronger consensus rating and higher possible upside, analysts plainly believe InspireMD is more favorable than GBS.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
GBS
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
InspireMD
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00

2.8% of GBS shares are owned by institutional investors. Comparatively, 44.8% of InspireMD shares are owned by institutional investors. 0.3% of GBS shares are owned by insiders. Comparatively, 34.1% of InspireMD shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

GBS has a net margin of 0.00% compared to InspireMD's net margin of -413.96%. InspireMD's return on equity of -69.42% beat GBS's return on equity.

Company Net Margins Return on Equity Return on Assets
GBSN/A -85.64% -54.42%
InspireMD -413.96%-69.42%-57.68%

In the previous week, GBS had 4 more articles in the media than InspireMD. MarketBeat recorded 4 mentions for GBS and 0 mentions for InspireMD. GBS's average media sentiment score of 0.09 beat InspireMD's score of 0.00 indicating that GBS is being referred to more favorably in the media.

Company Overall Sentiment
GBS Neutral
InspireMD Neutral

Summary

InspireMD beats GBS on 8 of the 15 factors compared between the two stocks.

Get GBS News Delivered to You Automatically

Sign up to receive the latest news and ratings for GBS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding GBS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

GBS vs. The Competition

MetricGBSSurgical & medical instruments IndustryMedical SectorNYSE Exchange
Market Cap$31.87M$64.45M$5.55B$20.85B
Dividend YieldN/AN/A3.75%3.65%
P/E Ratio-3.825.3428.0127.56
Price / SalesN/A155.93432.8159.11
Price / CashN/A18.4136.1622.29
Price / Book4.867.448.124.66
Net Income-$8.31M-$25.04M$3.25B$994.58M
7 Day Performance20.90%6.88%1.68%-0.29%
1 Month Performance12.63%3.57%7.30%4.90%
1 Year Performance39.87%57.51%32.89%11.14%

GBS Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
GBS
GBS
N/A$2.14
+0.5%
N/A+16.6%$31.87MN/A-3.827
NSPR
InspireMD
2.9069 of 5 stars
$2.30
-2.1%
$4.50
+95.7%
-0.4%$70.46M$7.03M-3.0750
CTCX
Carmell
N/A$2.65
-1.3%
N/A+269.2%$55.29M$32.84K0.0014
TMDIF
Titan Medical
N/A$0.33
-8.5%
N/A+900.0%$37.74M$17.63M-0.2650
HSAQ
Health Sciences Acquisitions Co. 2
N/A$3.03
+3.8%
N/A-63.6%$33.97MN/A0.004
RVP
Retractable Technologies
1.6941 of 5 stars
$0.66
-1.2%
N/A-41.7%$19.82M$33.75M-1.23240Positive News
Gap Up
PETV
PetVivo
N/A$0.78
+5.4%
N/A+31.4%$19.03M$1.05M-1.7420
BTCY
Biotricity
N/A$0.41
+0.1%
N/A-48.4%$10.21M$12.06M-0.3840News Coverage
Gap Up
INVO
INVO Bioscience
N/A$0.79
+1.7%
N/A+6.3%$3.01M$5.77M0.0025
TTOO
T2 Biosystems
2.3572 of 5 stars
$0.11
-0.9%
$5.00
+4,251.6%
-98.5%$2.42M$7.68M0.00180
DYNT
Dynatronics
N/A$0.09
-7.4%
N/A-64.6%$935K$33.60M-0.11200Gap Down

Related Companies and Tools


This page (NYSE:GBS) was last updated on 7/19/2025 by MarketBeat.com Staff
From Our Partners